Celcuity launches REVTORPYK for HR+/HER2- advanced breast cancerSep 30Regulatory decisionCelcuity Incgedatolisib
Loxo posts Phase 3 pirtobrutinib results; five more Lilly-linked trials updateSep 25Weekly roundup, 6 itemsabemaciclibbrenipatide
Tvardi's TTI-101 breast cancer trial posts results after early terminationSep 24Trial updateTTI-101Tvardi Therapeutics, Incorporated
Roche results post for two terminated Morpheus umbrella trials; new Phase 1/2 studies registeredAug 7Weekly roundup, 6 itemsatezolizumabBioLineRx, Ltd.
Relay Therapeutics files to sell up to $213 million more shares via TD CowenAug 6FinancingRelay Therapeutics, Inc.
Novartis posts BioItaLEE and China ribociclib results; registers three new studiesJul 10Weekly roundup, 5 itemsalpelisibinclisiran
Novartis: Mayzent label update approved; four real-world studies registered or recruitingJul 2Weekly roundup, 7 itemsalpelisibFludarabine
Sign inSign in